https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=Greenwich_LifeSciences%2C_Inc.Greenwich LifeSciences, Inc. - Revizia istoricului2026-05-16T03:28:34ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=Greenwich_LifeSciences,_Inc.&diff=421849&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei Greenwich LifeSciences, Inc. listata cu simbolul US.GLSI ==Descriere companie== Greenwich LifeSciences, Inc.(greenwichlifesciences.com) is a clinical stage biopharmaceutical company. The Company is developing, GP2, a breast cancer immunotherapy focused on preventing the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane peptide of the human epidermal growth factor receptor two (HER2/neu) protein, a cell surface rec...2024-09-18T17:59:24Z<p>Pagină nouă: Pagina dedicata companiei Greenwich LifeSciences, Inc. listata cu simbolul US.GLSI ==Descriere companie== Greenwich LifeSciences, Inc.(greenwichlifesciences.com) is a clinical stage biopharmaceutical company. The Company is developing, GP2, a breast cancer immunotherapy focused on preventing the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane peptide of the human epidermal growth factor receptor two (HER2/neu) protein, a cell surface rec...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei Greenwich LifeSciences, Inc. listata cu simbolul US.GLSI<br />
<br />
==Descriere companie==<br />
Greenwich LifeSciences, Inc.(greenwichlifesciences.com) is a clinical stage biopharmaceutical company. The Company is developing, GP2, a breast cancer immunotherapy focused on preventing the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane peptide of the human epidermal growth factor receptor two (HER2/neu) protein, a cell surface receptor protein that is expressed in a variety of common cancers. GP2 is delivered in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF) to induce GP2 peptide specific immunity. Following GP2 immunotherapy, CD8+ cytotoxic T lymphocytes (TCL) recognizes and destroys HER2/neu-expressing cancer cells. The Company’s GP2 treatment is administered through an intradermal injection by mixing GP2 peptide and GM-CSF at the time of administration. The GM-CSF is available in both liquid and lyophilized forms.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.GLSI" /><br />
<br />
==Ultimele stiri despre Greenwich LifeSciences, Inc. (US.GLSI)==<br />
<dynamicpagelist><br />
category=US.GLSI<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.GLSI]][[Categorie:Stiri despre companii]]</div>Admin